ArticleInternational journal of chronic obstructive pulmonary disease2025
Research Trends in Chronic Obstructive Pulmonary Disease (2005-2024): From Drug Therapy to Comprehensive Rehabilitation Strategies.
Article in International journal of chronic obstructive pulmonary disease, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- E-cigarette use among individuals with chronic obstructive pulmonary disease.Internal and emergency medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: Chronic obstructive pulmonary disease (COPD) is the third leading cause of death worldwide, which has driven efficient and economical management strategies to become a research focus. This study conducted a bibliometric analysis of drug treatment and comprehensive rehabilitation strategies for COPD, providing a scientific basis for future COPD management and offering valuable information and guidance to clinicians, researchers, and policymakers to optimize clinical treatment plans for COPD. Materials and Methods: Using the statistical analysis software CiteSpace6.4. R1, 11,417 articles exported from the Web of Science Core Collection and Scopus from January 1, 2005, to December 31, 2024, were quantitatively analyzed in terms of annual publication volume, countries, institutions, and keywords, and presented in the form of graphs. Results: After systematic screening, 3668 articles were included. The annual number of published papers in this field is increasing, but little cooperation has been observed between countries and institutions. In terms of contribution, the United States and the United Kingdom are in leading positions. At the institutional level, Sapienza University of Rome in Italy published the largest number of papers. The high-frequency keywords were pulmonary rehabilitation, quality of life, and bronchodilating agents. Keyword emergent analysis results showed that targeted drugs and intelligent healthcare are new research hotspots. Conclusion: The management of COPD has achieved a fundamental transformation from being "drug-centered" to "patient-centered". Research hotspots are mainly focused on bronchodilators and pulmonary rehabilitation, whereas targeted drugs and intelligent healthcare represent future directions of individualization and precision. In future, drugs, rehabilitation, and intelligent technologies should be integrated to build a full-process management model, and key empirical support should be provided through strengthened international collaboration.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.